Alternative therapies for localized prostate cancer

Beerlage, Harrie P.

doi:10.1007/s11918-003-0010-5

Cited by 2 publications

(2 citation statements)

References 56 publications

(32 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Essentially the role of TRUS as an imaging tool of the prostate remains vital for accurate needle placement and sampling of the prostate as well as taking volume measurement. TRUS technology has also become the mainstay of other image-guided prostate interventions such as brachytherapy, cryotherapy and high-intensity frequency ultrasound (HIFU), as well as being used in the evaluation of appropriate patients for treatment of benign prostatic hyperplasia (Beerlage, 2003).…”

Section: Resultsmentioning

confidence: 99%

The Development of the Modern Prostate Biopsy

Yeo¹,

Patel²,

Bach³

et al. 2011

Prostate Biopsy

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

The Development of the Modern Prostate Biopsy

Yeo¹,

Patel²,

Bach³

et al. 2011

Prostate Biopsy

View full text Add to dashboard Cite

“…Additionally, with early detection there has also been increased interest in focal "diseasetargeted" therapies, including interstitial brachytherapy, intensity-modulated radiotherapy, focal cryosurgery, and radiofrequency ablation which can potentially reduce treatment-related morbidity and allow patients to maintain their quality of life [19][20][21][22][23][24]. These therapies require an improved knowledge of the location and spatial extent of the disease within the gland.…”

Section: Prostate Cancer Diagnosis Prognosis and Treatmentmentioning

confidence: 99%

The role of magnetic resonance imaging (MRI) in prostate cancer imaging and staging at 1.5 and 3 Tesla: The Beth Israel Deaconess Medical Center (BIDMC) approach

Bloch

Lenkinski

Rofsky

2008

CBM

View full text Add to dashboard Cite

Management decisions for patients with prostate cancer present a dilemma for both patients and their clinicians because prostate cancers demonstrate a wide range in biologic activity, with the majority of cases not leading to a prostate cancer related death. Furthermore, the current treatment options have significant side effects, such as incontinence, rectal injury and impotence. Key elements for guiding appropriate treatment include: distinction of organ-confined disease from extracapsular extension (ECE); and determination of tumor volume and tumor grade, none of which have been satisfactorily accomplished in today's pre-treatment paradigm. Magnetic resonance imaging (MRI) has the capability to assess prostate tissue, both functionally and morphologically. MRI as a staging tool has not shown enough consistency or sufficient accuracy for widespread adoption in clinical practice; yet, recent technical developments in MRI have yielded improved results. At our institution we have combined the use of new endorectal 3 Tesla MRI technology, T2-weighted, and high spatial resolution dynamic-contrast enhanced (DCE) MRI to non-invasively assess the prostate with higher signal-to-noise ratio and spatial resolution than previously achieved. This approach allows assessment of prostate-tissue morphology and kinetics, thus providing a non-invasive tool for tumor detection and staging and, consequently, directing biopsy and treatment specifically to diseased areas for a pre-treatment evaluation that can assist in the rational selection of patients for appropriate prostate cancer therapy.

show abstract

Alternative therapies for localized prostate cancer

Cited by 2 publications

References 56 publications

The Development of the Modern Prostate Biopsy

The Development of the Modern Prostate Biopsy

The role of magnetic resonance imaging (MRI) in prostate cancer imaging and staging at 1.5 and 3 Tesla: The Beth Israel Deaconess Medical Center (BIDMC) approach

Contact Info

Product

Resources

About